Presentation is loading. Please wait.

Presentation is loading. Please wait.

Chapter 11 Paediatrics 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Paediatric.

Similar presentations


Presentation on theme: "Chapter 11 Paediatrics 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Paediatric."— Presentation transcript:

1 Chapter 11 Paediatrics 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Paediatric Working Group convened by Dr Sean Kennedy

2 2014 ANZDATA Registry 37 th Annual Report

3

4

5

6 Primary renal disease, incident patients Australia and New Zealand 2008-2013 Primary Renal Disease0-45-1010-1415-17Total GN8 (9%)20 (27%)25 (26%)37 (36%)90 (25%) - FSGS1 (1%)8 (11%)7 (7%)6 (6%)22 (6%) Familial GN3 (4%)-2 (2%)3 (3%)8 (2%) Reflux Nephropathy4 (5%)3 (4%)7 (7%)9 (9%)23 (6%) Polycystic Kidney Disease5 (6%)4 (5%)2 (2%)4 (4%)15 (4%) Medullary Cystic Disease-2 (3%)5 (5%)2 (2%)9 (3%) Posterior Urethral Valve10 (12%)1 (1%)13 (14%)2 (2%)26 (7%) Haemolytic Uraemic Syndrome6 (7%)1 (1%) 2 (2%)10 (3%) Hypoplasia/Dysplasia26 (31%)16 (22%)12 (13%)10 (10%)64 (18%) Diabetes--1 (1%) 2 (1%) Cortical Necrosis2 (2%)3 (4%)2 (2%)3 (3%)10 (3%) Interstitial Nephritis-1 (1%) -2 (1%) Cystinosis-1 (1%) -2 (1%) Uncertain-2 (3%)-4 (4%)6 (2%) Misc/Other20 (24%)11 (15%)17 (18%)19 (19%)67 (19%) Total857396102334

7 2014 ANZDATA Registry 37 th Annual Report Modality of Initial Renal Replacement Therapy By Year of First Treatment, Australia and New Zealand Age Group200820092010201120122013Total 0-9 Years2327222924 149 - HD6 (26%)4 (15%)5 (23%)10 (34%)8 (33%)6 (25%)39 (26%) - PD15 (65%)17 (63%)14 (64%)14 (48%)12 (50%)16 (67%)88 (59%) - Transplant2 (9%)6 (22%)3 (14%)5 (17%)4 (17%)2 (8%)22 (15%) 10-17 Years382725263930185 - HD22 (58%)12 (44%)13 (52%)8 (31%)16 (41%)12 (40%)83 (45%) - PD8 (21%)12 (44%)5 (20%)12 (46%)15 (38%)12 (40%)64 (35%) - Transplant8 (21%)3 (11%)7 (28%)6 (23%)8 (21%)6 (20%)38 (21%) Total615447556354334

8 2014 ANZDATA Registry 37 th Annual Report Modality of Prevalent Patients By Year of Treatment, Australia and New Zealand Current Treatment 200820092010201120122013Total HD35 (11%)29 (9%)30 (9%)29 (9%)30 (8%) 183 (9%) PD54 (17%)57 (18%)50 (15%)53 (16%)49 (14%)46 (13%)309 (16%) Transplant225 (72%)229 (73%)244 (75%)250 (75%)274 (78%)277 (78%)1499 (75%) Total314315324332353 1991

9 2014 ANZDATA Registry 37 th Annual Report

10

11

12

13 Graft Numbers 2004 - 2013 Australia and New Zealand Graft Number 2004200520062007200820092010201120122013 135472628453640445543 24143433215

14 2014 ANZDATA Registry 37 th Annual Report Donor Source by Year 2004 - 2015, Number (% of Transplants) Donor Type2004200520062007200820092010201120122013 LD pre-emptive5 (13%)10 (21%)7 (23%)8 (26%)9 (18%)9 (23%)10 (23%)10 (22%)12 (21%)8 (17%) LD not pre-emptive19 (49%)20 (42%)15 (50%)13 (42%)24 (49%)16 (41%)19 (44%)10 (22%)26 (46%)20 (42%) DBD15 (38%)17 (35%)8 (27%)9 (29%)13 (27%)12 (31%)11 (26%)21 (46%)17 (30%)18 (38%) DCD0 (0%)1 (2%)0 (0%)1 (3%)3 (6%)2 (5%)3 (7%)5 (11%)1 (2%)2 (4%) Total39483031493943465648

15 2014 ANZDATA Registry 37 th Annual Report Antibody Use for Induction Immunosuppression, Number receiving (%) CountryType of Agent20092010201120122013 Australia Intravenous immunoglobulin1 (2.9%)0 (0.0%)2 (4.8%)0 (0.0%)2 (4.7%) Anti-CD2533 (97.1%)35 (92.1%)37 (88.1%)41 (89.1%)36 (83.7%) Rituximab0 (0.0%)1 (2.6%)0 (0.0%) T cell depleting polyclonal Ab1 (2.9%)2 (5.3%)2 (4.8%)1 (2.2%)1 (2.3%) Total new transplants3438424643 New Zealand Intravenous immunoglobulin0 (0.0%) 1 (10.0%)0 (0.0%) Anti-CD250 (0.0%)1 (20.0%)4 (100.0%)10 (100.0%)4 (80.0%) Rituximab0 (0.0%) 1 (20.0%) T cell depleting polyclonal Ab0 (0.0%) Total new transplants554105

16 2014 ANZDATA Registry 37 th Annual Report

17

18

19

20

21

22

23

24

25 Patient and Graft Survival, Paediatric Transplant Recipients 2004 - 2013 (95% CI) OutcomeTransplant year (N)6 months1 year3 years5 years Patient 2004-05 (n=87)10099 (92-100)98 (91-99)96 (89-99) 2006-07 (n=61)100 98 (89-100) 2008-09 (n=88)100 2010-11 (n=89)10099 (92-100) - 2012-13 (n=104)99 (91-100) -- Graft 2004-05 (n=87)97 (90-99)95 (88-98)88 (79-94)76 (66-84) 2006-07 (n=61)93 (83-97)90 (79-95)82 (70-90)79 (66-87) 2008-09 (n=88)94 (87-98) 87 (78-93)84 (74-90) 2010-11 (n=89)10098 (91-99)96 (88-98)- 2012-13 (n=104)99 (91-100)97 (90-99)--

26 2014 ANZDATA Registry 37 th Annual Report Cause of Graft Loss, Transplants Performed 2004-2013 by Age at Transplant Cause of Graft Loss0-45-910-1415-17Total Death with function02125 Acute rejection12159 Chronic allograft nephropathy1310923 Vascular21238 Technical00112 Glomerulonephritis02417 Non-compliance00044 Other11327 Total511222765

27 2014 ANZDATA Registry 37 th Annual Report Cause of Graft Loss, Transplants Performed 2004-2013 by Age at Graft Loss Cause of Graft Loss0-45-910-1415-17Total Death with function01045 Acute rejection03047 Chronic allograft nephropathy0031417 Vascular20338 Technical00112 Glomerulonephritis01416 Non-compliance00022 Other01326 Total26143153

28 2014 ANZDATA Registry 37 th Annual Report

29

30 Type of Rejection Timing of Rejection Type of Rejection 200420052006200720082009201020112012 <6 months No biopsy256201320 Cellular562462332 ABMR000000100 Cellular + ABMR 1 010010000 6-24 months No biopsy3310101-- Cellular25141236-- ABMR0001000-- Cellular + ABMR 1 0000102--


Download ppt "Chapter 11 Paediatrics 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Paediatric."

Similar presentations


Ads by Google